Abstract Development of a new drug for the treatment of lung disease is a complex and time
consuming process involving numerous disciplines of basic and applied sciences. During …

Over the past years, advanced in vitro pulmonary platforms have witnessed exciting
developments that are pushing beyond traditional preclinical cell culture methods. Here, we …

Noninvasive ventilation (NIV) and high-flow nasal cannula (HFNC) are increasingly used for
patients with acute respiratory failure. Some patients receiving these therapies might also …

Pulmonary delivery has gained increased interests over the past few decades. For
conditions within the respiratory tract, targeted drug delivery directly to the site of action can …

The first book offering a global overview of fundamental microfluidics and the wide range of
possible applications, for example, in chemistry, biology, and biomedical science. As such, it …

There is increasing interest in the use of so-called 'extrafine'aerosols to target the small
airways in the management of asthma and COPD. Using previously presented deposition …

Background: The objective of this study was to compare aerosol deposition predictions of a
new whole-airway CFD model with available in vivo data for a dry powder inhaler (DPI) …

Nebulizers have a number of advantages for the delivery of inhaled pharmaceutical
aerosols, including the use of aqueous formulations and the ability to deliver process …

Tuberculosis (TB) is a major global health burden. The emergence of the human
immunodeficiency virus (HIV) epidemic and drug resistance has complicated global TB …

Delivery of drugs to the lungs via dry powder inhaler (DPI) is a promising approach for the
treatment of both local pulmonary conditions and systemic diseases. Though DPIs are …